secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2026-04-09T23:59:59+00:00
Accession:  0001104659-26-041507
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics fails to convene special meeting due to lack of quorum; will call new meeting
--------------------------------------------------------------------------------

- Special Meeting on April 9, 2026 lacked quorum; meeting could not convene.
- Company will call new meeting to seek approval for issuance of up to 16,184,560 shares upon exercise of New Warrants.
- Under Inducement Agreement dated Oct 16, 2025, company must continue calling meetings every 60 days until approval or warrants expire.
- Stockholders will receive new proxy materials with date/time of adjourned meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465926041507/0001104659-26-041507-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465926041507/tm2611468d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-041507

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer